Evidence map›Paper›PMID 40256584›Full record

ArticleArchives of Razi Institute2024

Reactive oxygen species (ROS) are a crucial factor in the anticancer activity of

M Dinarvand, F Sharifnia, Z Jangravi

Abstract read
In one paragraph

Article in Archives of Razi Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M DinarvandDepartment of biology, North Tehran Branch, Islamic Azad University, Tehran, Iran.
F SharifniaDepartment of biology, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Z JangraviDepartment of Biochemistry, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, skin cancer is a main public health challenge whose incidence is continuously increasing. Given the limitations of conventional t herapies, new research and novel therapies may be promising for reducing skin cancer morbidity and mortality. Phytochemicals are attractive resources for new therapy design in cancer research due to their cost-effectiveness and lower side effects. In the present study, the anti-cancer activity of

Indexed as

Antineoplastic Agents, PhytogenicPlant ExtractsReactive Oxygen SpeciesSkin NeoplasmsApoptosisCell CycleCell Line, TumorHumansAntineoplastic Agents, PhytogenicPlant ExtractsReactive Oxygen SpeciesA431cell lineAqueous extractOliveriadecumbensROSSkin cancer

Identifiers

PMID40256584
PMCPMC12004055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.